Active substanceNeomycin + Nystatin + Polymyxin BNeomycin + Nystatin + Polymyxin B
Similar drugsTo uncover
  • Polizinax Virgo
    emulsioncapsules the vagina. 
  • Dosage form: & nbspemulsion for intravaginal administration in capsules
    Composition:

    1 capsule contains:

    Active substances:

    Neomycin sulfate 35 000 ME

    Polymyxin B sulfate 35 000 ME

    Nystatin 100 000 ME

    Excipients: hydrogenated soybean oil, dimethicone 1000, Tefos 63®: palmitic esters and esters of stearic acid.

    Capsule shell composition: gelatin, glycerol, dimethicone 1000, purified water.

    Description:

    Soft capsules from light yellow up to light brown color, oval with pointed elongated end. Content capsules :, oil emulsion from light-yellow to brown.

    Pharmacotherapeutic group:Antibiotic combined (antibiotics: aminoglycoside + polyene + cyclic polypeptide)
    ATX: & nbsp

    G.01.A.X   Other antiseptics and antimicrobials for the treatment of gynecological diseases

    Pharmacodynamics:

    Has a bactericidal effect on gram-positive (Staphylococus aureus, corynebacteria, etc.) and Gram-negative microorganisms (Enterococus faecium, Enterobacter aerogenes, Escherichia coli, Hemophilus influenzae, Proteus vulgaris, Klebsiella pneumoniae, Mycobacterium tuberculosis, Pseudomonas aeruginosa, Ureaplasma urealyticum). Has a fungicidal effect on pathogenic fungi, especially yeast-like genera Candida albicans, Cryptococcus, Hystoplasma. Improves trophic processes in the vaginal mucosa.

    Pharmacokinetics:

    Evenly distributed over the vaginal mucosa, exerting local bactericidal and fungicidal action. Virtually not absorbed from the surface of the vaginal mucosa.

    Indications:

    Treatment.

    nonspecific, fungal, mixed vaginitis, vulvovaginitis and cervicovaginitis;

    Prevention.

    - before surgery in the genital area;

    - before intrauterine diagnostic procedures;

    Contraindications:Allergic reaction to any component of the drug.
    Pregnancy and lactation:during pregnancy is not recommended without consulting a doctor. If during You will find that you are pregnant; only he can decide on the need to continue treatment. During breastfeeding, the drug should be avoided.
    Dosing and Administration:

    For intravaginal administration. One capsule after the evening toilet, before going to bed. Notching the pointed end, and lightly pressing the capsule, enter the contents of the capsule into the vagina. After the drug is introduced into the vagina, the capsule is discarded in the garbage.The course of treatment is 6 days. For the prevention of the drug is used for 6 days.

    In case of skipping of the drug, it is necessary to resume treatment in the usual dose.

    Side effects:Allergic reactions to the components of the drug. With prolonged use, a systemic manifestation of side effects of aminoglycosides is possible, which is enhanced in cases of renal insufficiency.
    Interaction:

    It is not recommended to use in combination with spermicides, t. may decrease the activity of the drug.

    Special instructions:The drug is designed specifically for use in girls and adolescent girls. The timing of the drug should be limited in order to prevent the formation of resistance to it of certain pathogens and the risk of reinfection. In case of kidney failure, consult a doctor. During treatment, it is necessary to refrain from using intravaginal tampons. Do not interrupt treatment during menstruation.
    Effect on the ability to drive transp. cf. and fur:
    Form release / dosage:

    Emulsion for intravaginal administration in capsules. 3 capsules in PVC / aluminum blister.

    1 or 2 blisters with instructions for use in a cardboard bundle.
    Packaging:(3) - packings, cellular, planimetric (1) - packs, cardboard
    (3) - packings, cellular, outline (2) - packs, cardboard
    Storage conditions:

    At a temperature of 15 to 25 ° C, out of the reach of children.

    Shelf life:

    1,5 years.

    Do not use after the expiration date printed on the package.

    Terms of leave from pharmacies:On prescription
    Registration number:LSR-000023/09
    Date of registration:11.01.2009
    The owner of the registration certificate:Laboratory Innotech InternationalLaboratory Innotech International France
    Manufacturer: & nbsp
    Representation: & nbspLaboratory Innotech International Laboratory Innotech International France
    Information update date: & nbsp07.08.2015
    Illustrated instructions
      Instructions
      Up